LAUSR

Current Biologics in Asthma Treatment.

Sign Up to like & get
recommendations!
1 Published in 2022 at "Seminars in respiratory and critical care medicine"

DOI: 10.1055/s-0042-1753486

Abstract: Uncontrolled asthma and/or severe asthma causes significant impairments in quality of life and is often a huge health care burden. Monoclonal antibodies have been an important addition to the therapeutic management of patients with moderate… read more here.

Keywords: inflammation; current biologics; biologics asthma; severe asthma ... See more keywords